Conjunctivitis in adolescent patients aged 12-17 with moderate-to-severe atopic dermatitis treated with tralo-kinumab up to week 52: results from the phase 3 ecztra 6 trial

SKIN The Journal of Cutaneous Medicine(2022)

引用 0|浏览0
暂无评分
关键词
tralokinumab,adolescent patients,moderate-to-severe
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要